NewGenIvf Group (NIVF) Competitors $0.93 -0.06 (-5.76%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$0.91 -0.02 (-2.57%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NIVF vs. BACK, BTTX, UPHL, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, and PIIIWShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include IMAC (BACK), Better Therapeutics (BTTX), UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), and P3 Health Partners (PIIIW). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Its Competitors IMAC Better Therapeutics UpHealth Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners NewGenIvf Group (NASDAQ:NIVF) and IMAC (NASDAQ:BACK) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk. Which has preferable earnings and valuation, NIVF or BACK? NewGenIvf Group has higher revenue and earnings than IMAC. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNewGenIvf Group$5.43M0.74-$520KN/AN/AIMAC$72.05K1.44-$9.42MN/AN/A Do insiders & institutionals hold more shares of NIVF or BACK? 66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 5.8% of IMAC shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by company insiders. Comparatively, 12.3% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more risk & volatility, NIVF or BACK? NewGenIvf Group has a beta of -0.03, indicating that its share price is 103% less volatile than the S&P 500. Comparatively, IMAC has a beta of 2.18, indicating that its share price is 118% more volatile than the S&P 500. Is NIVF or BACK more profitable? Company Net Margins Return on Equity Return on Assets NewGenIvf GroupN/A N/A N/A IMAC N/A N/A -325.44% Does the media prefer NIVF or BACK? In the previous week, IMAC had 7 more articles in the media than NewGenIvf Group. MarketBeat recorded 13 mentions for IMAC and 6 mentions for NewGenIvf Group. NewGenIvf Group's average media sentiment score of 0.64 beat IMAC's score of 0.30 indicating that NewGenIvf Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NewGenIvf Group 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive IMAC 1 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryNewGenIvf Group beats IMAC on 6 of the 9 factors compared between the two stocks. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.03M$7.31B$5.50B$9.02BDividend YieldN/A2.77%5.38%4.10%P/E RatioN/A27.9427.5520.29Price / Sales0.7428.20389.87112.84Price / CashN/A22.0836.6357.47Price / Book-0.036.698.075.68Net Income-$520K$233.06M$3.17B$249.04M7 Day Performance-9.42%1.74%2.83%3.30%1 Month Performance-69.41%3.97%3.70%5.20%1 Year Performance-99.52%35.84%35.41%21.37% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf GroupN/A$0.93-5.8%N/A-99.5%$4.03M$5.43M0.00N/APositive NewsBACKIMACN/A$0.05-23.3%N/A-97.0%$104K$72.05K0.00180Gap DownBTTXBetter TherapeuticsN/A$0.00flatN/A-99.0%$5KN/A0.0040High Trading VolumeUPHLUpHealthN/A$0.00flatN/A-100.0%$4K$130M0.001,750ACONWAclarionN/A$0.04-2.7%N/AN/A$0.00$54.60K0.007Gap DownAONCAmerican Oncology NetworkN/A$14.00+3.7%N/A+870.9%$0.00$1.34B0.001,520DHACWDigital Health AcquisitionN/A$0.04flatN/A-74.4%$0.00N/A0.00N/AFMSFresenius Medical Care AG & Co. KGaA2.5706 of 5 stars$28.60+1.4%$27.80-2.8%+46.2%$0.00$20.63B25.541,384Positive NewsLFMDPLifeMDN/A$24.17-0.1%N/A+0.8%$0.00$234.01M0.00230OTRKPOntrakN/A$0.23-6.8%N/A-25.5%$0.00$10.84M0.00250News CoveragePositive NewsGap DownHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01+5.7%N/A-86.6%$0.00$1.49B0.00500Positive NewsGap Down Related Companies and Tools Related Companies IMAC Alternatives Better Therapeutics Alternatives UpHealth Alternatives Aclarion Alternatives American Oncology Network Alternatives Digital Health Acquisition Alternatives Fresenius Medical Care AG & Co. KGaA Alternatives LifeMD Alternatives Ontrak Alternatives P3 Health Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NIVF) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
